SmashGene™ Transfection Reagent (14571)
Roll over image to zoom in Click on image to zoom
SmashGene™ Transfection Reagent (14571)
Download Product Brochure

SmashGene™ Transfection Reagent (14571)

- High titers, no enhancer needed
- Lower overall cost of production
- Broad flexibility

SKU Size: 14571-1 (1mL)
Contact Us for Pricing

Looking for large quantities? Submit a Bulk Request.

SmashGene™ is a next-generation transfection reagent that consistently delivers higher titers alone than leading competitor reagents with enhancers. By eliminating the need for enhancers, it simplifies workflows, reduces variability, and lowers overall production costs through decreased bioreactor demand and streamlined downstream processing.

Designed to support both process development and scale-up, SmashGene™ accelerates development timelines and improves reproducibility across stages. It is compatible with both adherent and suspension cell systems and performs reliably across a wide range of media, offering flexibility for diverse process strategies.

Fully synthetic and manufactured in the USA, SmashGene™ ensures reliable supply, consistent quality, and greater control from flask to bioreactor.

SmashGene performance graphs
Store At Temperature -20°C
Shipping Condition Dry Ice

High yield, Low complexity

  • Produce higher titers compared to competitor reagents on the market with no enhancers required, resulting in a streamlined, cost-effective transfection workflow.

Lower total cost of production

  • Fewer components, fewer bioreactor runs, and reduced downstream processing translate into a significantly lower cost per dose

Simplified workflows

  • Streamlined transfection setup with fewer components enables faster, more reproducible execution from bench to scale-up.

Broad flexibility

  • Performs reliably across adherent and suspension cells and a wide range of media conditions, supporting multiple process strategies.

Made in the USA

  • Fully synthetic and manufactured in-house in Pennsylvania for reliable supply and quality control.
  • Upstream process development for cell and gene therapy  
  • Academic and translational research 

SmashGene™ is a next-generation transfection reagent that consistently delivers higher titers alone than leading competitor reagents with enhancers. By eliminating the need for enhancers, it simplifies workflows, reduces variability, and lowers overall production costs through decreased bioreactor demand and streamlined downstream processing.

Designed to support both process development and scale-up, SmashGene™ accelerates development timelines and improves reproducibility across stages. It is compatible with both adherent and suspension cell systems and performs reliably across a wide range of media, offering flexibility for diverse process strategies.

Fully synthetic and manufactured in the USA, SmashGene™ ensures reliable supply, consistent quality, and greater control from flask to bioreactor.

SmashGene performance graphs
Store At Temperature -20°C
Shipping Condition Dry Ice

High yield, Low complexity

  • Produce higher titers compared to competitor reagents on the market with no enhancers required, resulting in a streamlined, cost-effective transfection workflow.

Lower total cost of production

  • Fewer components, fewer bioreactor runs, and reduced downstream processing translate into a significantly lower cost per dose

Simplified workflows

  • Streamlined transfection setup with fewer components enables faster, more reproducible execution from bench to scale-up.

Broad flexibility

  • Performs reliably across adherent and suspension cells and a wide range of media conditions, supporting multiple process strategies.

Made in the USA

  • Fully synthetic and manufactured in-house in Pennsylvania for reliable supply and quality control.
  • Upstream process development for cell and gene therapy  
  • Academic and translational research 

You may also like

Recently viewed